Literature DB >> 8970203

p53 and Ki-67 immunoreactivity and nuclear morphometry of 'carcinoma-in-adenoma' and adenoma of the gall-bladder.

K Takei1, H Watanabe, T Itoi, T Saito.   

Abstract

Twenty intramucosal tumors of "carcinoma-in-adenoma' and 43 adenomas (39 pyloric gland type, 4 intestinal type) of the gall-bladder were studied to establish more precise histological criteria of carcinoma or adenoma in cases of "carcinoma in pyloric gland type adenoma', to compare carcinoma in adenoma with pure, that is, without adenomatous components, carcinoma, and to confirm the benign nature of spindle cell foci in the adenomas. Ki-67 and p53 immunostaining and nuclear morphometry were used. Eight pure intramucosal cancers were used as controls. The formalin-fixed, paraffin-embedded sections were stained with p53 and Ki-67 antibodies. Spindle cell foci were observed only in the adenoma area of the pyloric gland type, with a frequency of 23% in 39 adenomas, and of 45% in 20 tumors of carcinoma-in-adenoma. Ki-67 staining was negative in 129 of 130 spindle cell foci examined, regardless of their size, and positive in only one focus (550 microns in size, Ki-67 index 0.2%). All of the spindle cell foci were negative for p53 stain. The Ki-67 positive index was 36.6 +/- 5.6% in the 8 pure carcinomas, and 12.5 +/- 1.9% in the cancer areas of 16 tumors with carcinoma-in-adenoma, while it was 7.9 +/- 1.7% in the adenoma areas of 16 tumors with carcinoma-in-adenoma and 4.9 +/- 0.5% in the 32 pure pyloric gland adenomas. The p53-protein over-expression was found in seven of eight pure intramucosal cancers, and in one of 16 cancer components of carcinoma-in-adenoma. However, it was not found in any of 16 adenoma components of carcinoma-in-adenoma, and 35 adenomas. Cells of the cancer tissue of carcinoma-in-adenoma showed a significantly larger nuclear area and a larger nuclear minor axis than those of the pyloric gland type adenomas, as well as other architectural and cytologic abnormalities differing from the features of adenomas. These results suggest that clustered spindle cells do not indicate a malignant transformation of adenoma cells and that carcinomas in carcinoma-in-adenoma are different from pyloric gland type adenomas in terms of morphology and proliferative activity. Moreover, the results of the present study indicate that carcinomas in carcinoma-in-adenoma are lower in malignancy than pure carcinomas, and that their genetic abnormality may differ from that of pure carcinomas.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8970203     DOI: 10.1111/j.1440-1827.1996.tb03569.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  11 in total

1.  Pyloric gland adenoma arising in Barrett's esophagus with mucin immunohistochemical and molecular cytogenetic evaluation.

Authors:  Ryoji Kushima; Michael Vieth; Ken-Ichi Mukaisho; Rie Sakai; Hidetoshi Okabe; Takanori Hattori; Horst Neuhaus; Franz Borchard; Manfred Stolte
Journal:  Virchows Arch       Date:  2005-04-19       Impact factor: 4.064

2.  Aberrant expression of an "intestinal marker" Cdx2 in pyloric gland adenoma of the gallbladder.

Authors:  Yoji Wani; Kenji Notohara; Masayoshi Fujisawa
Journal:  Virchows Arch       Date:  2008-10-09       Impact factor: 4.064

3.  [Tubular adenoma of the stomach with special reference to the Japanese criteria and pyloric gland adenoma].

Authors:  R Kushima; M Vieth
Journal:  Pathologe       Date:  2010-05       Impact factor: 1.011

Review 4.  Gastric-type well-differentiated adenocarcinoma and pyloric gland adenoma of the stomach.

Authors:  Ryoji Kushima; Michael Vieth; Franz Borchard; Manfred Stolte; Ken-ichi Mukaisho; Takanori Hattori
Journal:  Gastric Cancer       Date:  2006       Impact factor: 7.370

5.  Immunohistochemical analysis of pyloric gland adenomas using a series of Mucin 2, Mucin 5AC, Mucin 6, CD10, Ki67 and p53.

Authors:  Michael Vieth; Ryoji Kushima; Ken-ichi Mukaisho; Rie Sakai; T Kasami; Takanori Hattori
Journal:  Virchows Arch       Date:  2010-09-09       Impact factor: 4.064

6.  Pyloric gland adenoma: a clinico-pathological analysis of 90 cases.

Authors:  M Vieth; R Kushima; F Borchard; M Stolte
Journal:  Virchows Arch       Date:  2003-03-26       Impact factor: 4.064

7.  Bouveret's syndrome with a concomitant incidental T1 gallbladder cancer.

Authors:  Masahiro Shinoda; Koichi Aiura; Yoshiyuki Yamagishi; Yohei Masugi; Kiminori Takano; Shotaro Maruyama; Tomoyuki Irino; Kaoru Takabayashi; Yoshinori Hoshino; Shin Nishiya; Taizo Hibi; Shigeyuki Kawachi; Minoru Tanabe; Masakazu Ueda; Michiie Sakamoto; Toshifumi Hibi; Yuko Kitagawa
Journal:  Clin J Gastroenterol       Date:  2010-09-04

8.  Lowering of tumor interstitial fluid pressure reduces tumor cell proliferation in a xenograft tumor model.

Authors:  Matthias Hofmann; Maike Guschel; August Bernd; Jürgen Bereiter-Hahn; Roland Kaufmann; Christa Tandi; Helge Wiig; Stefan Kippenberger
Journal:  Neoplasia       Date:  2006-02       Impact factor: 5.715

9.  Gallbladder carcinoma: the role of p53 protein overexpression and Ki-67 antigen expression as prognostic markers.

Authors:  Luis A Hidalgo Grau; Josep M Badia; Carmen Admella Salvador; Teresa Soler Monsó; Josep Feliu Canaleta; Josep M Gubern Nogués; Javier Suñol Sala
Journal:  HPB (Oxford)       Date:  2004       Impact factor: 3.647

10.  Pyloric gland adenoma: a case report.

Authors:  Ekrem Cakar; Savaş Bayrak; Esra Paşaoğlu; Sükrü Colak; Hasan Bektaş; Ayhan Güneyi
Journal:  Case Rep Gastroenterol       Date:  2013-09-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.